Kronos Bio, Inc.
Open: 3:52 PM
KRON Stock Price Graph
KRON Stock Price Today
Kronos Bio, Inc. (KRON) stock rallied over 1.69% intraday to trade at $1.2 a share on NASDAQ. The stock opened with a loss of -25.21% at $0.89 and touched an intraday high of $0.91, rising 0.84% against the last close of $1.19. The Kronos Bio, Inc. in stock market went to a low of $0.82 during the session.
KRON Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
KRON Stock Price History Chart
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally administered, selective spleen tyrosine kinase inhibitor for acute myeloid leukemia patients. The company planned registrational phase 3 clinical trial of ENTO in combination with induction chemotherapy in acute myeloid leukemia patients with NPM1 mutations. It is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors, which is in phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in San Mateo, California.
Frequently Asked Questions
What is the current Kronos Bio, Inc. (KRON) stock price?
Kronos Bio, Inc. (NASDAQ: KRON) stock price is $1.20 in the last trading session. During the trading session, KRON stock reached the peak price of $0.91 while $0.82 was the lowest point it dropped to. The percentage change in KRON stock occurred in the recent session was 1.69% while the dollar amount for the price change in KRON stock was $0.02.
KRON's industry and sector of operation?
The NASDAQ listed KRON is part of Biotechnology industry that operates in the broader Healthcare sector. Kronos Bio, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics.
Who are the executives of KRON?
Dr. Yasir B. Al-Wakeel BCh, BM, MA
Chief Financial Officer & Head of Corporation Devel.
Ms. Barbara A. Kosacz J.D.
Chief Operating Officer, Sec. & Gen. Counsel
Ms. Allison Frisbee J.D.
Senior Vice President & Deputy Gen. Counsel
Dr. Norbert W. Bischofberger Ph.D.
Pres, Chief Executive Officer & Director
How KRON did perform over past 52-week?
KRON's closing price is 0.53% higher than its 52-week low of $0.816 where as its distance from 52-week high of $3.07 is -0.68%.
How many employees does KRON have?
Number of KRON employees currently stands at N/A. KRON operates from 1300 South El Camino Real, San Mateo, CA 94402, US.
Link for KRON official website?
Official Website of KRON is: https://kronosbio.com
How do I contact KRON?
How many shares of KRON are traded daily?
KRON stock volume for the day was 199802.00 shares. The average number of KRON shares traded daily for last 3 months was 262.19 Thousands.
What is the market cap of KRON currently?
The market value of KRON currently stands at $69.98 Million with its latest stock price at $1.20 and N/A of its shares outstanding.